N. Pavlidis

Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

G. Catimel, Jaap Verweij, Vera Mattijssen et al. · Annals of Oncology · 1994 · 259 citations

Medicine, Oncology, Pharmacology +7

Docetaxel (TaxotereTM) is active in non-small-cell lung cancer: a phase II trial of the EORTC early clinical trials group (ECTG)

Thomas Cerny, Steven Kaplan, N. Pavlidis et al. · British Journal of Cancer · 1994 · 161 citations · Full text

Medicine, Oncology, Pharmacology +10

The diagnosis and management of gastric cancer: expert discussion and recommendations from the 12th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2010

Eric Van Cutsem, Mario Dicato, Ravit Geva et al. · Annals of Oncology · 2011 · 130 citations · Full text

Medicine, Oncology, Surgery +17

Population Pharmacokinetics and Pharmacodynamics of Paclitaxel and Carboplatin in Ovarian Cancer Patients: A Study by the European Organization for Research and Treatment of Cancer-Pharmacology and Molecular Mechanisms Group and New Drug Development Group

Markus Joerger, Alwin D. R. Huitema, Dick J. Richel et al. · Clinical Cancer Research · 2007 · 116 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC)

Enriqueta Felip, Rolf A. Stahel, N. Pavlidis · Annals of Oncology · 2005 · 114 citations

Medicine, Oncology, Surgery +14